Valeria Dipasquale, Rossella Morello, Claudio Romano
{"title":"Formula with real food ingredients for tube feeding in children with neuromuscular disorders (NMDs): A case series","authors":"Valeria Dipasquale, Rossella Morello, Claudio Romano","doi":"10.1016/j.hnm.2025.200306","DOIUrl":null,"url":null,"abstract":"<div><div>The aim of this case series was to evaluate the tolerability, safety, and efficacy of an enteral formula containing food-derived ingredients for pediatric patients with neuromuscular disorders (NMDs). Children (1–17 years) with (i) a formally diagnosed NMD and (ii) exclusive enteral nutrition were enrolled. Patients received a nutritionally complete 1.2 kcal/mL enteral formula containing food-derived ingredients (peas, green beans, peaches, carrots, and chicken). Weight, body mass index (BMI), mid-upper-arm-circumference (MUAC) standard deviation (SD), and symptoms were assessed at the baseline (formula start; visit 1) and at 6 months (visit 2). Five NMD children with spinal muscular atrophy were included. Weight and BMI increased significantly after a mean of 2.5 months: weight −3.5 (V1) vs. −2.5 Z-score (V2) (p = 0.004) and BMI -3.8 (V1) vs. - 3 Z-score (V2) (p = 0.03). MUAC SD increased over the study period as well, even though the increase was not statistically significant (p = 0.231). All patients well tolerated the formula, and a relief from gastrointestinal symptoms was reported. The enteral formula containing food-derived ingredients may be a valid option in tube feeding management for children with NMDs. A small sample size and retrospective design limit the generalizability of findings. Further data (e.g., larger sample size, longer follow-up period, or different NMD subtypes) are needed.</div></div>","PeriodicalId":36125,"journal":{"name":"Human Nutrition and Metabolism","volume":"40 ","pages":"Article 200306"},"PeriodicalIF":1.9000,"publicationDate":"2025-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Human Nutrition and Metabolism","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S266614972500009X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
The aim of this case series was to evaluate the tolerability, safety, and efficacy of an enteral formula containing food-derived ingredients for pediatric patients with neuromuscular disorders (NMDs). Children (1–17 years) with (i) a formally diagnosed NMD and (ii) exclusive enteral nutrition were enrolled. Patients received a nutritionally complete 1.2 kcal/mL enteral formula containing food-derived ingredients (peas, green beans, peaches, carrots, and chicken). Weight, body mass index (BMI), mid-upper-arm-circumference (MUAC) standard deviation (SD), and symptoms were assessed at the baseline (formula start; visit 1) and at 6 months (visit 2). Five NMD children with spinal muscular atrophy were included. Weight and BMI increased significantly after a mean of 2.5 months: weight −3.5 (V1) vs. −2.5 Z-score (V2) (p = 0.004) and BMI -3.8 (V1) vs. - 3 Z-score (V2) (p = 0.03). MUAC SD increased over the study period as well, even though the increase was not statistically significant (p = 0.231). All patients well tolerated the formula, and a relief from gastrointestinal symptoms was reported. The enteral formula containing food-derived ingredients may be a valid option in tube feeding management for children with NMDs. A small sample size and retrospective design limit the generalizability of findings. Further data (e.g., larger sample size, longer follow-up period, or different NMD subtypes) are needed.